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Sister Study
Hopes to Answer
Breast Cancer
Questions
Working out of their office in Research
Triangle Park, North Carolina, a pair of
NIEHS researchers are laying the groundwork
for what may prove to be a landmark study of
the possible interplay between genetics and
the environment in the development of breast
cancer. Principal investigator Dale Sandler,
acting chief of the institute’s Epidemiology
Branch, and colleague Clarice Weinberg,
chief of the Biostatistics Branch, plan to
recruit 50,000 female volunteers aged 35–70
whose sisters have been diagnosed with breast
cancer and follow their health over a period of
time. Eventually the researchers will evaluate
the 1,500 or so of the women that they esti-
mate will develop breast cancer during the
initial five years of follow-up, analyzing envi-
ronmental, genetic, and health data captured
at the outset of the study.
Sandler and Weinberg are
absorbed in the extensive
work necessary to develop a
study of this size, scope, and
importance. Besides develop-
ing an overall plan for the
study, the researchers are
meeting with focus groups,
doing feasibility studies, devel-
oping applications and ques-
tionnaires, and marshaling the
considerable technical, finan-
cial, and professional resources
necessary to undertake the
study, which will run at least
10 years. 
“Despite great interest in
trying to discover environ-
mental causes of breast cancer,
we don’t have a lot of evi-
dence,” Sandler says. “We
don’t have a lot of clues; there
are no obvious places to start.”
Some evidence suggests that
pesticides and solvents may
cause breast cancer. Electro-
magnetic fields have been the
focus of other studies, though
Sandler cautions that evidence
from those studies is inconsis-
tent. Phthalates, compounds
used as plasticizers and fixa-
tives and found in diverse
products including cosmetics
and lotions, may be a culprit
as well. A recent study by the
Centers for Disease Control
and Prevention that measured phthalate con-
centrations in urine samples found evidence
of widespread exposure. The highest levels of
exposure to monobutyl phthalate, a repro-
ductive toxicant in animals, were found in
women of reproductive age. Phthalates are
classified among chemicals thought to disrupt
reproductive hormones. From that informa-
tion, the scientists suspect a breast cancer
link, too. 
Sandler says retrospective and case–con-
trol studies such as the Long Island Breast
Cancer Study Project and the Carolina Breast
Cancer Study have the advantage of including
large numbers of breast cancer cases, but
because they are retrospective, they may not
accurately characterize levels of exposure prior
to the onset of breast cancer. Instead, she and
Weinberg believe a prospective study will be
better able to address factors that cannot easily
be measured retrospectively or that may
change once a woman develops breast cancer. 
Besides collecting biologic and environ-
mental samples such as blood, urine, tap
water, and household dust from subjects at
the outset of the study, researchers will also
use questionnaires to gather a multitude of
data about health history, past environmental
exposures, and lifestyle. Sandler believes analy-
ses based on samples collected well before the
onset of disease will yield more accurate data
for at least two reasons. “One,” she explains,
“women’s exposure patterns could change
once they are sick, and if you are measuring
something that reflects recent exposures, like
diet in the last twenty-four hours, what you
get may not represent usual exposure levels.
Two, the illness itself or its treatment may lead
to changes in the levels. . . . If you are measur-
ing something intrinsic [for example, hor-
mones or immune markers], you would not
know if the levels were high because the
women were sick or if high levels in the past
caused the women to become sick.”
To execute such an ambitious study, the
research team will need large numbers of par-
ticipants. Though Sandler and Weinberg
expect recruiting the large cohort necessary to
generate a statistically viable group to be a
challenge, they plan to surmount this hurdle
by going after precisely the par-
ticipants with the most motiva-
tion to enroll and stay
enrolled—women who have a
sister with breast cancer. 
“First-degree relatives, espe-
cially sisters, have about two
times the risk of developing
breast cancer as the average
woman,” Sandler says. Sisters of
breast cancer patients are also
likely to be within the same age
range (and therefore at an age
when they are at risk for devel-
oping breast cancer) and likely to
have been exposed to the same
environmental risk factors dur-
ing early childhood. And of
course they share many of the
same genes. Sandler says sisters
are also likely to share genetic
polymorphisms that might affect
the way a person’s system han-
dles carcinogens or repairs DNA. 
The study should also fuel
rewarding professional collabo-
rations within the NIEHS, the
NIH, and eventually with extra-
mural colleagues too. “We’re
already building partners [such
as the National Cancer Insti-
tute] into the study’s design,”
Sandler asserts. 
In focus groups of women of
diverse socioeconomic, racial,
and lifestyle backgrounds,
Sandler and Weinberg have 
discovered that the women have
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cer patients, they share a common concern
over the disease. That, says Sandler, makes
them more likely to want to participate in the
study and more willing to comply with the
demands of the study, which will lead to a
better response rate and higher retention rate
over time. 
The researchers are building a Web site
for the project, developing a marketing plan
to attract study participants (including adver-
tisements in women’s magazines and cancer
publications), finalizing questionnaires, and
securing preliminary scientific reviews to val-
idate the integrity of the study’s design. “We
also have to work things out like standard-
ized blood sampling,” Weinberg adds.
“We’re hoping by the first of next year to
phase in the study,” Sandler says. “We’ll go
into three or four test cities to try the mar-
keting plan and see if it gets women to
respond. Then we’ll work on getting the
bugs out and assess what we need to do to
get an ethnically diverse group of women,”
she adds. In this first phase, 2000 women
will be enrolled in the study. Sandler and
Weinberg expect it to take three years to
enroll all 50,000 participants.
Women enrolled in the study will pro-
vide periodic updates during the study and
will be given follow-up questionnaires to
account, for example, for diet changes or
menopause. “By starting with a cohort of
women and following them over time, we’ll
be able to look at many conditions of con-
cern to women in addition to breast cancer,
like osteoporosis and thyroid and autoim-
mune disorders,” Sandler says. “This [data-
base of study information] will be a rich
resource for lots of nested studies,” she adds,
“and for addressing new questions that come
up over time.” 
Over time, the study cohort’s value to the
researchers will increase. “If we do the study
for five years, we’ll have enough [breast can-
cer] cases to look at the interaction between
many of the exposures of interest and the
genes of interest,” Sandler explains. “Going
ten years for rare exposures or rare genes . . .
will give us even more statistical power.”
–Jennifer Medlin
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NTP Announces Bioassay Results
On 3 May 2001, the National Toxicology Program (NTP) presented
for public review five technical reports by the NTP’s Board of
Scientific Counselors Technical Reports Subcommittee at the
NIEHS. NTP technical reports describe an ongoing series
of toxicity and carcinogenicity studies conducted on
chemical or physical agents to which humans are exposed.
The findings from these studies are unique information
and knowledge used by health and regulatory agencies in
making decisions that affect public health.
Each report reviewed at the meeting involved a series
of short- and long-term studies in which male and
female rats and/or mice were given a range of doses of test
chemical followed by extensive histopathologic examina-
tion plus characterizations of clinical chemistry, metabolism
and disposition, and genotoxicity. The NTP applies established
criteria to classify the strength of the experimental evidence for car-
cinogenicity in these studies, and the board’s subcommittee review includ-
ed a rigorous evaluation of the studies’ findings.
Acrylonitrile and methacrylonitrile—Over 1 million tons of acrylonitrile are used
each year in the production of acrylic fibers, elastomers, plastics, and resins.
Acrylonitrile is known to be a multisite carcinogen in rats and has been classified
as a likely human carcinogen. The NTP studied the effects of acrylonitrile given
to mice by gavage and found clear evidence of carcinogenic activity in the
forestomach and harderian gland of the eye for both males and females. 
Methacrylonitrile is used as an alternative or replacement for acrylonitrile in
some of the same applications. No evidence of carcinogenicity was seen for
methacrylonitrile in male or female rats or mice. Methacrylonitrile also tested
negative in a battery of genetic toxicity assays. 
o- and p-Nitrotoluene—The ortho- and para- isomers of nitrotoluene are widely
used in production of agricultural and rubber chemicals and a variety of dyes
for cotton, wool, silk, leather, and paper. o-Nitrotoluene yielded clear evidence
of carcinogenic activity in all four sex/species groups, producing skin and mam-
mary gland neoplasms in male and female rats and hemangiosarcomas and large
intestine carcinomas in male and female mice. In supplementary mechanistic
studies, NIEHS scientists identified p53 and β -catenin gene mutations in
hemangiosarcomas taken from mice exposed to o-nitrotoluene; similar muta-
tions were rarely seen in spontaneously occurring hemangiosarcomas from con-
trol animals.
By contrast, p-nitrotoluene yielded some evidence of carcinogenic activity in
female rats (clitoral gland neoplasms) and equivocal evidence of carcinogenic
activity in male rats and male mice.
Citral—Citral is a lemon flavoring and fragrance used widely in foods, cosmetics, and
other consumer products. Because of the volatility and reactivity of the chemical,
it was administered inside starch microcapsules mixed with the animals’ feed.
This was the NTP’s first report using this route of administration in long-term
studies. A marginal increase in malignant lymphomas in female mice was judged
to be equivocal evidence of carcinogenic activity; there was no evidence of car-
cinogenicity of citral in rats or in male mice.
A listing of all NTP technical reports including an abstract of each study is
available from the NTP home page, located at http://ntp-server.niehs.nih.gov/
(see NTP Study Information). The Environmental Health Information Service
(EHIS) also maintains a library of NTP technical reports, adding new reports as
available. Access to the EHIS is available online at http://ehis.niehs.nih.gov/ or by
calling 1-800-315-3010. –Mary S. Wolfe
For more information, check out 
http://www.4sister.org/ 
or contact 1-877-4SISTER